Pink Sheet is part of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By


Hoodia spammer settles

This article was originally published in The Tan Sheet

Executive Summary

The Federal Trade Commission accepts a settlement with hoodia marketers charged under the U.S. Safe Web Act with making "false and unsubstantiated" claims about their products through spam e-mails, according to a July 15 release. In an October 2007 complaint, FTC said Wyoming-based Spear Systems falsely claimed its products - falsely marketed as hoodia - enabled rapid, permanent weight loss, and the firm's promotional e-mails violated the CAN-SPAM Act by including deceptive subject lines and lacking an opt-out link (1"The Tan Sheet" Oct. 15, 2007, p. 13). Under the terms of the settlement, Spear Systems must surrender $29,000 in alleged ill-gotten gains...

You may also be interested in...

Hoodia Firm Ordered To Halt Unsubstantiated Ads In First FTC Safe Web Claim

An international spamming enterprise marketing hoodia weight-loss and human hormone anti-aging products was the first operation targeted by the Federal Trade Commission under the new U.S. Safe Web Act

COVID-19: FDA Schedules 4 More Virtual Town Halls Through October

The US agency has announced another month of webinars aimed at labs and manufacturers that are developing – or have developed – diagnostic tests for the novel coronavirus.

EMA Starts ‘Rolling Review’ Of AstraZeneca’s COVID-19 Vaccine

The European Medicines Agency says its rolling review tool should speed up the evaluation of AstraZeneca’s COVID-19 vaccine.





Ask The Analyst

Please Note: You can also Click below Link for Ask the Analyst
Ask The Analyst

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts